Zepp Health Corporation
New York Stock ExchangeTotal Valuation
Zepp Health Corporation carries a market capitalization of 54.71M, placing it among publicly traded companies globally. Its enterprise value stands at 8.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 54.71M |
| Enterprise Value | 8.49B |
Share Statistics
Zepp Health Corporation currently has 234.89M shares outstanding.
| Shares Outstanding | 234.89M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.03, and the price-to-book ratio stands at 44.95.
| PE Ratio | N/A |
| PS Ratio | 2.03 |
| PB Ratio | 44.95 |
| P/TBV Ratio | 51.14 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 30.76 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 1,240.55 |
Financial Position
Zepp Health Corporation maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 132.98, indicating elevated leverage, while an interest coverage ratio of -5.41 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.90 |
| Quick Ratio | 0.48 |
| Debt / Equity | 132.98 |
| Debt / EBITDA | -7.08 |
| Interest Coverage | -5.41 |
Financial Efficiency
| Return on Equity (ROE) | -21.23 |
| Return on Assets (ROA) | -7.86 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | 2.51M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Zepp Health Corporation's stock has declined approximately -92.30304% over the past 52 weeks. The 50-day moving average sits at 4.74, while the 200-day moving average is 12.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -92.30304% |
| 50-Day Moving Average | 4.74 |
| 200-Day Moving Average | 12.75 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Zepp Health Corporation generated 276.03M in revenue and converted that into -43.56M in net income, yielding earnings per share of -2.75. EBITDA reached -34.75M, while operating income came in at -34.75M.
| Revenue | 276.03M |
| Gross Profit | 106.50M |
| Operating Income | -34.75M |
| Pretax Income | -38.68M |
| Net Income | -43.56M |
| EBITDA | -34.75M |
| EBIT | -34.75M |
| Earnings Per Share (EPS) | -2.75 |
Balance Sheet
Zepp Health Corporation holds 69.66M in cash and equivalents against 245.98M in total debt, resulting in a net debt position of 175.25M. Total book value stands at 184.97M, with working capital of -31.86M providing operational flexibility.
| Cash & Cash Equivalents | 69.66M |
| Total Debt | 245.98M |
| Net Debt | 175.25M |
| Equity (Book Value) | 184.97M |
| Book Value Per Share | 0.79 |
| Working Capital | -31.86M |
Margins
Zepp Health Corporation operates with a gross margin of 38.58, reflecting its pricing power and cost economics. The operating margin of -12.59 and net profit margin of -15.78 provide insight into operational efficiency.
| Gross Margin | 38.58 |
| Operating Margin | -12.59 |
| Pretax Margin | -14.01 |
| Profit Margin | -15.78 |
| EBITDA Margin | -12.59 |
Stock Splits
Zepp Health Corporation's most recent stock split took place on September 16, 2024 with a 4:1 split ratio.
| Last Split Date | 9/16/2024 |
| Split Ratio | 4:1 |
Scores
Zepp Health Corporation posts an Altman Z-Score of 13.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 13.43 |